The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth.
MarketsandMarkets forecast, the global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%.
The study utilized four steps to estimate the current market size for dental biomaterials. Firstly, exhaustive secondary research was done to collect information regarding the market, peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chain through primary research. The third step involved the use of both top-down and bottom-up approaches to estimate the complete market size. Finally, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=198160556
Metallic biomaterials segment is expected to hold the largest share of the dental biomaterials market during the forecast period.
Metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials the metallic biomaterials segment accounted for the largest share in 2018. The large share of this segment can be attributed to the increasing penetration of Dental Implants and the wide applications of metallic biomaterials in dentistry.
Implantology applications to dominate the dental biomaterials market through the forecast period.
Implantology, prosthodontics, orthodontics, and other applications. In 2018, the implantology application segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry, growing dental tourism in emerging markets, and increasing disposable incomes in developing countries.
Dental implant and prosthetic manufacturers to hold the largest share of the dental biomaterial market during the forecast period.
Dental implant and prosthetic manufacturers, dental laboratories, dental hospitals and clinics, and dental academies and research institutes. In 2018, the dental implant and prosthetic manufacturers segment accounted for the largest of the market. The large share of this segment can be attributed to the increasing penetration of dental implants and prosthetics, growing adoption of CAD/CAM systems in dental clinics and laboratories, increasing number of dental practices, and the rising awareness on oral diseases.
Download PDF Brochure @
Geographically, the global dental biomaterials industry is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, Europe held the largest share of this market, and this is primarily attributed to the growing geriatric population, increasing government expenditure on oral healthcare, higher adoption of the dental biomaterials to manufacture implants and other dental products, and growing number of dental hospitals and clinics.
The prominent players in the global market are Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).